1. International Agency for Research on Cancer. World Health Organization. GLOBOCAN2008. Available at: http://globocan.iarc.fr/. Accessed July 16, 2013.

2. MutoT, BusseyHJ, MorsonBC. The evolution of cancer of the colon and rectum. Cancer1975;36:2251. CrossRef

3. SnoverDC. Update on the serrated pathway to colorectal carcinoma. Hum Pathol2011;42:1. CrossRef

4. SnoverDC, JassJR, Fenoglio‐PreiserC, et al.Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept. Am J Clin Pathol2005;124:380. CrossRef

5. AtkinWS, MorsonBC, CuzickJ. Long‐term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med1992;326:658. CrossRef

6. FuchsCS, GiovannucciEL, ColditzGA, et al.A prospective study of family history and the risk of colorectal cancer. N Engl J Med1994;331:1669. CrossRef

7. LindorNM, PetersenGM, HadleyDW, et al.Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA2006;296:1507. CrossRef

8. MilesA, CockburnJ, SmithRA, et al.A perspective from countries using organized screening programs. Cancer2004;101:1201. CrossRef

9. SegnanN, PatnickJ, von KarsaL(eds). European Guidelines for Quality Assurance in Colorectal Cancer Screening and Diagnosis, 1st edn. Luxembourg: Publications Office of the European Union; 2010.

10. LeeJK, LevinTR, CorleyDA. The road ahead: what if gastroenterologists were accountable for preventing colorectal cancer?Clin Gastroenterol Hepatol2013;11:204. CrossRef

11. HoffG, DominitzJA. Contrasting US and European approaches to colorectal cancer screening: which is best?Gut2010;59:407. CrossRef

12. BensonVS, PatnickJ, DaviesAK, et al.Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int J Cancer2008;122:1357. CrossRef

13. WestNJ, PoullisAP, LeicesterRJ. The NHS Bowel Cancer Screening Programme – a realistic approach with additional benefits. Colorectal Dis2008;10:708. CrossRef

14. LoganRF, PatnickJ, NickersonC, et al.Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests. Gut2012;61:1439. CrossRef

15. RabeneckL, RumbleRB, ThompsonF, et al.Fecal immunochemical tests compared with guaiac fecal occult blood tests for population‐based colorectal cancer screening. Can J Gastroenterol2012;26:131.

16. SungJJ, LauJY, YoungGP, et al.Asia Pacific consensus recommendations for colorectal cancer screening. Gut2008;57:1166. CrossRef

17. DuffyMJ, van RossumLG, van TurenhoutST, et al.Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paper. Int J Cancer2011;128:3. CrossRef

18. KewenterJ, BjorkS, HaglindE, et al.Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects. Cancer1988;62:645. CrossRef

19. KewenterJ, BrevingeH, EngarasB, et al.Results of screening, rescreening, and follow‐up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjects. Scand J Gastroenterol1994;29:468. CrossRef

20. KewenterJ, BrevingeH, EngarasB, et al.Follow‐up after screening for colorectal neoplasms with fecal occult blood testing in a controlled trial. Dis Colon Rectum1994;37:115. CrossRef

21. LindholmE, BrevingeH, HaglindE. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. Br J Surg2008;95:1029. CrossRef

22. MandelJS, BondJH, ChurchTR, et al.Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med1993;328:1365. CrossRef

23. MandelJS, ChurchTR, BondJH, et al.The effect of fecal occult‐blood screening on the incidence of colorectal cancer. N Engl J Med2000;343:1603. CrossRef

24. MandelJS, ChurchTR, EdererF, et al.Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst1999;91:434. CrossRef

25. ShaukatA, MonginSJ, GeisserMS, et al.Long‐term mortality after screening for colorectal cancer. N Engl J Med2013;369:1106. CrossRef

26. JorgensenOD, KronborgO, FengerC. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut2002;50:29. CrossRef

27. KronborgO, FengerC, OlsenJ, et al.Randomised study of screening for colorectal cancer with faecal‐occult‐blood test. Lancet1996;348:1467. CrossRef

28. KronborgO, JorgensenOD, FengerC, et al.Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scand J Gastroenterol2004;39:846. CrossRef

29. HardcastleJD, ChamberlainJO, RobinsonMH, et al.Randomised controlled trial of faecal‐occult‐blood screening for colorectal cancer. Lancet1996;348:1472. CrossRef

30. RobinsonMH, HardcastleJD, MossSM, et al.The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer. Gut1999;45:588. CrossRef

31. ScholefieldJH, MossS, SufiF, et al.Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial. Gut2002;50:840. CrossRef

32. ScholefieldJH, MossSM, ManghamCM, et al.Nottingham trial of faecal occult blood testing for colorectal cancer: a 20‐year follow‐up. Gut2012;61:1036. CrossRef

33. HewitsonP, GlasziouP, WatsonE, et al.Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol2008;103:1541. CrossRef

34. EtzioniDA, YanoEM, RubensteinLV, et al.Measuring the quality of colorectal cancer screening: the importance of follow‐up. Dis Colon Rectum2006;49:1002. CrossRef

35. PaszatL, RabeneckL, KieferL, et al.Endoscopic follow‐up of positive fecal occult blood testing in the Ontario FOBT Project. Can J Gastroenterol2007;21:379.

36. YabroffKR, WashingtonKS, LeaderA, et al.Is the promise of cancer‐screening programs being compromised? Quality of follow‐up care after abnormal screening results. Med Care Res Rev2003;60:294. CrossRef

37. LeeSJ, BoscardinWJ, Stijacic‐CenzerI, et al.Time lag to benefit after screening for breast and colorectal cancer: meta‐analysis of survival data from the United States, Sweden, United Kingdom, and Denmark. BMJ2013;346:e8441.

38. FaivreJ, DancourtV, LejeuneC, et al.Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology2004;126:1674. CrossRef

39. LibbyG, BrewsterDH, McClementsPL, et al.The impact of population‐based faecal occult blood test screening on colorectal cancer mortality: a matched cohort study. Br J Cancer2012;107:255. CrossRef

40. QuinteroE, CastellsA, BujandaL, et al.Colonoscopy versus fecal immunochemical testing in colorectal‐cancer screening. N Engl J Med2012;366:697. CrossRef

41. KaminskiMF, BretthauerM, ZauberAG, et al.The NordICC Study: rationale and design of a randomized trial on colonoscopy screening for colorectal cancer. Endoscopy2012;44:695. CrossRef

42. ClinicalTrials.gov. Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM). Available at: http://clinicaltrials.gov/show/NCT01239082 Accessed July 16, 2013.

43. BossuytPM, IrwigL, CraigJ, et al.Comparative accuracy: assessing new tests against existing diagnostic pathways. BMJ2006;332:1089. CrossRef

44. LordSJ, IrwigL, SimesRJ. When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized trials?Ann Intern Med2006;144:850. CrossRef

45. LevinB, LiebermanDA, McFarlandB, et al.Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi‐Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology2008;134:1570. CrossRef

46. WhitlockEP, LinJS, LilesE, et al.Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med2008;149:638. CrossRef

47. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med2008;149:627. CrossRef

48. RexDK, JohnsonDA, AndersonJC, et al.American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol2009;104:739. CrossRef

49. HalloranSP, LaunoyG, ZappaM. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition – Faecal occult blood testing. Endoscopy2012;44(Suppl 3):SE65. CrossRef

50. AllisonJE, SakodaLC, LevinTR, et al.Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst2007;99:1462. CrossRef

51. van RossumLG, van RijnAF, LaheijRJ, et al.Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology2008;135:82. CrossRef

52. GrazziniG, VisioliCB, ZorziM, et al.Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening?Br J Cancer2009;100:259. CrossRef

53. HolL, WilschutJA, van BallegooijenM, et al.Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut‐off levels. Br J Cancer2009;100:1103. CrossRef

54. van RossumLG, van RijnAF, LaheijRJ, et al.Cutoff value determines the performance of a semi‐quantitative immunochemical faecal occult blood test in a colorectal cancer screening programme. Br J Cancer2009;101:1274. CrossRef

55. ParkDI, RyuS, KimYH, et al.Comparison of guaiac‐based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. Am J Gastroenterol2010;105:2017. CrossRef

56. HolL, van LeerdamME, van BallegooijenM, et al.Screening for colorectal cancer: randomised trial comparing guaiac‐based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut2010;59:62. CrossRef

57. GrazziniG, VenturaL, ZappaM, et al.Influence of seasonal variations in ambient temperatures on performance of immunochemical faecal occult blood test for colorectal cancer screening: observational study from the Florence district. Gut2010;59:1511. CrossRef

58. HoffmanRM, SteelS, YeeEF, et al.Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac‐based fecal occult blood tests: a randomized, controlled trial. Prev Med2010;50:297. CrossRef

59. HundtS, HaugU, BrennerH. Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Ann Intern Med2009;150:162. CrossRef

60. DentersMJ, DeutekomM, BossuytPM, et al.Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer. Gastroenterology2012;142:497. CrossRef

61. SelbyJV, FriedmanGD, QuesenberryCPJr, et al.A case‐control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med1992;326:653. CrossRef

62. NewcombPA, NorfleetRG, StorerBE, et al.Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst1992;84:1572. CrossRef

63. NewcombPA, StorerBE, MorimotoLM, et al.Long‐term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence. J Natl Cancer Inst2003;95:622. CrossRef

64. MullerAD, SonnenbergA. Protection by endoscopy against death from colorectal cancer. A case‐control study among veterans. Arch Intern Med1995;155:1741. CrossRef

65. MullerAD, SonnenbergA. Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case‐control study of 32,702 veterans. Ann Intern Med1995;123:904. CrossRef

66. AtkinWS, EdwardsR, Kralj‐HansI, et al.Once‐only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet2010;375:1624. CrossRef

67. SegnanN, ArmaroliP, BonelliL, et al.Once‐only sigmoidoscopy in colorectal cancer screening: follow‐up findings of the Italian Randomized Controlled Trial–SCORE. J Natl Cancer Inst2011;103:1310. CrossRef

68. SchoenRE, PinskyPF, WeissfeldJL, et al.Colorectal‐cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med2012;366:2345. CrossRef

69. HoffG, GrotmolT, SkovlundE, et al.Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ2009;338:b1846. CrossRef

70. Thiis‐EvensenE, HoffGS, SauarJ, et al.Population‐based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand J Gastroenterol1999;34:414. CrossRef

71. ElmunzerBJ, HaywardRA, SchoenfeldPS, et al.Effect of flexible sigmoidoscopy‐based screening on incidence and mortality of colorectal cancer: a systematic review and meta‐analysis of randomized controlled trials. PLoS Med2012;9:e1001352. CrossRef

72. LiebermanDA, WeissDG, HarfordWV, et al.One‐time screening for colorectal cancer with combined fecal occult‐blood testing and examination of the distal colon. N Engl J Med2001;345:555. CrossRef

73. KatoJ, MorikawaT, KuriyamaM, et al.Combination of sigmoidoscopy and a fecal immunochemical test to detect proximal colon neoplasia. Clin Gastroenterol Hepatol2009;7:1341. CrossRef

74. WinawerSJ, ZauberAG, HoMN, et al.Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med1993;329:1977. CrossRef

75. ZauberAG, WinawerSJ, O'BrienMJ, et al.Colonoscopic polypectomy and long‐term prevention of colorectal‐cancer deaths. N Engl J Med2012;366:687. CrossRef

76. LiebermanDA, WeissDG, BondJH, et al.Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med2000;343:162. CrossRef

77. ImperialeTF, WagnerDR, LinCY, et al.Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med2000;343:169. CrossRef

78. PodolskyDK. Going the distance – the case for true colorectal‐cancer screening. N Engl J Med2000;343:207. CrossRef

79. SchoenfeldP, CashB, FloodA, et al.Colonoscopic screening of average‐risk women for colorectal neoplasia. N Engl J Med2005;352:2061. CrossRef

80. WinawerSJ, FletcherRH, MillerL, et al.Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology1997;112:594. CrossRef

81. WinawerS, FletcherR, RexD, et al.Colorectal cancer screening and surveillance: clinical guidelines and rationale‐Update based on new evidence. Gastroenterology2003;124:544. CrossRef

82. U.S. Preventive Services Task Force. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med2002;137:129. CrossRef

83. Centers for Disease Control and Prevention (CDC). Screening for colorectal cancer – United States, 1992–1993, and new guidelines. MMWR Morb Mortal Wkly Rep1996;45:107.

84. JanesGR, BlackmanDK, BolenJ C, et al.Surveillance for use of preventive health‐care services by older adults, 1995–1997. MMWR CDC Surveill Summ1999;48:51.

85. Centers for Disease Control and Prevention (CDC). Trends in screening for colorectal cancer – United States, 1997 and 1999. MMWR Morb Mortal Wkly Rep2001;50:162.

86. Centers for Disease Control and Prevention (CDC). Vital signs: colorectal cancer screening, incidence, and mortality – United States, 2002–2010. MMWR Morb Mortal Wkly Rep2011;60:884.

87. ChenX, WhiteMC, PeipinsLA, et al.Increase in screening for colorectal cancer in older Americans: results from a national survey. J Am Geriatr Soc2008;56:1511. CrossRef

88. SwanJ, BreenN, CoatesRJ, et al.Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer2003;97:1528. CrossRef

89. MeissnerHI, BreenN, KlabundeCN, et al.Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev2006;15:389. CrossRef

90. PhillipsKA, LiangSY, LadabaumU, et al.Trends in colonoscopy for colorectal cancer screening. Med Care2007;45:160. CrossRef

91. RobertsonRH, BurkhardtJH, PowellMP, et al.Trends in colon cancer screening procedures in the US Medicare and Tricare populations: 1999–2001. Prev Med2006;42:460. CrossRef

92. FentonJJ, TancrediDJ, GreenP, et al.Persistent racial and ethnic disparities in up‐to‐date colorectal cancer testing in medicare enrollees. J Am Geriatr Soc2009;57:412. CrossRef

93. SchenckAP, PeacockSC, KlabundeCN, et al.Trends in colorectal cancer test use in the medicare population, 1998–2005. Am J Prev Med2009;37:1. CrossRef

94. HarewoodGC, LiebermanDA. Colonoscopy practice patterns since introduction of medicare coverage for average‐risk screening. Clin Gastroenterol Hepatol2004;2:72. CrossRef

95. SonnenbergA, AmorosiSL, LaceyMJ, et al.Patterns of endoscopy in the United States: analysis of data from the Centers for Medicare and Medicaid Services and the National Endoscopic Database. Gastrointest Endosc2008;67:489. CrossRef

96. BaxterNN, GoldwasserMA, PaszatLF, et al.Association of colonoscopy and death from colorectal cancer. Ann Intern Med2009;150:1. CrossRef

97. BrennerH, HoffmeisterM, ArndtV, et al.Protection from right‐ and left‐sided colorectal neoplasms after colonoscopy: population‐based study. J Natl Cancer Inst2010;102:89. CrossRef

98. NeugutAI, LebwohlB. Colonoscopy vs sigmoidoscopy screening: getting it right. JAMA2010;304:461. CrossRef

99. CitardaF, TomaselliG, CapocacciaR, et al.Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut2001;48:812. CrossRef

100. RobertsonDJ, GreenbergER, BeachM, et al.Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology2005;129:34. CrossRef

101. KahiCJ, ImperialeTF, JuliarBE, et al.Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol2009;7:770; quiz 11. CrossRef

102. MulderSA, van SoestEM, DielemanJP, et al.Exposure to colorectal examinations before a colorectal cancer diagnosis: a case‐control study. Eur J Gastroenterol Hepatol 2010;22:437. CrossRef

103. SinghH, NugentZ, DemersAA, et al.The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer. Gastroenterology2010;139:1128. CrossRef

104. BaxterNN, SutradharR, ForbesSS, et al.Analysis of administrative data finds endoscopist quality measures associated with postcolonoscopy colorectal cancer. Gastroenterology2011;140:65. CrossRef

105. BaxterNN, WarrenJL, BarrettMJ, et al.Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty. J Clin Oncol2012;30:2664. CrossRef

106. BrennerH, Chang‐ClaudeJ, SeilerCM, et al.Protection from colorectal cancer after colonoscopy: a population‐based, case‐control study. Ann Intern Med2011;154:22. CrossRef

107. NishiharaR, WuK, LochheadP, et al.Long‐term colorectal‐cancer incidence and mortality after lower endoscopy. N Engl J Med2013;369:1095. CrossRef

108. SawhneyMS, FarrarWD, GudisevaS, et al.Microsatellite instability in interval colon cancers. Gastroenterology2006;131:1700. CrossRef

109. FarrarWD, SawhneyMS, NelsonDB, et al.Colorectal cancers found after a complete colonoscopy. Clin Gastroenterol Hepatol2006;4:1259. CrossRef

110. ArainMA, SawhneyM, SheikhS, et al.CIMP status of interval colon cancers: another piece to the puzzle. Am J Gastroenterol2010;105:1189. CrossRef

111. PabbyA, SchoenRE, WeissfeldJL, et al.Analysis of colorectal cancer occurrence during surveillance colonoscopy in the dietary Polyp Prevention Trial. Gastrointest Endosc2005;61:385. CrossRef

112. RobertsonDJ, LiebermanDA, WinawerSJ, et al.Colorectal cancers soon after colonoscopy: a pooled multicohort analysis. Gut2014;63:949. CrossRef

113. SanduleanuS, MascleeAM, MeijerGA. Interval cancers after colonoscopy‐insights and recommendations. Nat Rev Gastroenterol Hepatol2012;9:550. CrossRef

114. HewettDG, KahiCJ, RexDK. Does colonoscopy work?J Natl Compr Canc Netw2010;8:67; quiz 7.

115. SinghH, TurnerD, XueL, et al.Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10‐year interval between colonoscopies. JAMA2006;295:2366. CrossRef

116. BrennerH, Chang‐ClaudeJ, SeilerCM, et al.Long‐term risk of colorectal cancer after negative colonoscopy. J Clin Oncol2011;29:3761. CrossRef

117. WinawerSJ, ZauberAG, O'BrienMJ, et al.Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med1993;328:901. CrossRef

118. LiebermanDA, WeissDG, HarfordWV, et al.Five‐year colon surveillance after screening colonoscopy. Gastroenterology2007;133:1077. CrossRef

119. ImperialeTF, GlowinskiEA, Lin‐CooperC, et al.Five‐year risk of colorectal neoplasia after negative screening colonoscopy. N Engl J Med2008;359:1218. CrossRef

120. RexDK, PetriniJL, BaronTH, et al.Quality indicators for colonoscopy. Am J Gastroenterol2006;101:873.

121. LiebermanD, NadelM, SmithRA, et al.Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable. Gastrointest Endosc2007;65:757. CrossRef

122. SoetiknoRM, KaltenbachT, RouseRV, et al.Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults. JAMA2008;299:1027. CrossRef

123. van RijnJC, ReitsmaJB, StokerJ, et al.Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol2006;101:343. CrossRef

124. KahiCJ, HewettDG, NortonDL, et al.Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy. Clin Gastroenterol Hepatol2011;9:42. CrossRef

125. PohlH, SrivastavaA, BensenSP, et al.Incomplete polyp resection during colonoscopy‐results of the complete adenoma resection (CARE) study. Gastroenterology2013;144:74. CrossRef

126. BarclayRL, VicariJJ, DoughtyAS, et al.Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med2006;355:2533. CrossRef

127. KaminskiMF, RegulaJ, KraszewskaE, et al.Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med2010;362:1795. CrossRef

128. CorleyDA, JensenCD, MarksAR. Can we improve adenoma detection rates? A systematic review of intervention studies. Gastrointest Endosc2011;74:656. CrossRef

129. BresslerB, PaszatLF, ChenZ, et al.Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population‐based analysis. Gastroenterology2007;132:96. CrossRef

130. CooperGS, XuF, Barnholtz SloanJS, et al.Prevalence and predictors of interval colorectal cancers in medicare beneficiaries. Cancer2012;118:3044. CrossRef

131. le ClercqCM, BouwensMW, RondaghEJ, et al.Postcolonoscopy colorectal cancers are preventable: a population‐based study. Gut2014;63:957. CrossRef

132. SinghH, NugentZ, MahmudSM, et al.Predictors of colorectal cancer after negative colonoscopy: a population‐based study. Am J Gastroenterol2010;105:663; quiz 74. CrossRef

133. AdlerA, WegscheiderK, LiebermanD, et al.Factors determining the quality of screening colonoscopy: a prospective study on adenoma detection rates, from 12,134 examinations (Berlin colonoscopy project 3, BECOP‐3). Gut2013;62:236. CrossRef

134. PoxCP, AltenhofenL, BrennerH, et al.Efficacy of a nationwide screening colonoscopy program for colorectal cancer. Gastroenterology2012;142:1460. CrossRef

135. KewenterJ, BrevingeH. Endoscopic and surgical complications of work‐up in screening for colorectal cancer. Dis Colon Rectum1996;39:676. CrossRef

136. AtkinWS, CookCF, CuzickJ, et al.Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet2002;359:1291. CrossRef

137. SegnanN, SenoreC, AndreoniB, et al.Baseline findings of the Italian multicenter randomized controlled trial of "once‐only sigmoidoscopy" – SCORE. J Natl Cancer Inst2002;94:1763. CrossRef

138. WhitlockEP, LinJ, LilesE, et al.Screening for Colorectal Cancer: An Updated Systematic Review. Rockville MD: Agency for Healthcare Research and Quality (US); 2008 Oct.

139. ImperialeTF, RansohoffDF, ItzkowitzSH, et al.Fecal DNA versus fecal occult blood for colorectal‐cancer screening in an average‐risk population. N Engl J Med2004;351:2704. CrossRef

140. ItzkowitzSH, JandorfL, BrandR, et al.Improved fecal DNA test for colorectal cancer screening. Clin Gastroenterol Hepatol2007;5:111. CrossRef

141. AhlquistDA, SargentDJ, LoprinziCL, et al.Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med2008;149:441, W81. CrossRef

142. AhlquistDA, TaylorWR, MahoneyDW, et al.The stool DNA test is more accurate than the plasma septin 9 test in detecting colorectal neoplasia. Clin Gastroenterol Hepatol2012;10:272. CrossRef

143. AhlquistDA, ZouH, DomanicoM, et al.Next‐generation stool DNA test accurately detects colorectal cancer and large adenomas. Gastroenterology2012;142:248; quiz e25–6. CrossRef

144. KahiCJ, AndersonJC, RexDK. Screening and surveillance for colorectal cancer: state of the art. Gastrointest Endosc2013;77:335. CrossRef

145. WinawerSJ, StewartET, ZauberAG, et al.A comparison of colonoscopy and double‐contrast barium enema for surveillance after polypectomy. N Engl J Med2000;342:1766. CrossRef

146. PickhardtPJ, ChoiJR, HwangI, et al.Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med2003;349:2191. CrossRef

147. MulhallBP, VeerappanGR, JacksonJL. Meta‐analysis: computed tomographic colonography. Ann Intern Med2005;142:635. CrossRef

148. JohnsonCD, ChenMH, ToledanoAY, et al.Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med2008;359:1207. CrossRef

149. PickhardtPJ, HassanC, HalliganS, et al.Colorectal cancer: CT colonography and colonoscopy for detection – systematic review and meta‐analysis. Radiology2011;259:393. CrossRef

150. ZalisME, BlakeMA, CaiW, et al.Diagnostic accuracy of laxative‐free computed tomographic colonography for detection of adenomatous polyps in asymptomatic adults: a prospective evaluation. Ann Intern Med2012;156:692. CrossRef

151. HassanC, PickhardtPJ. Cost‐effectiveness of CT colonography. Radiol Clin North Am2013;51:89. CrossRef

152. Van GossumA, Munoz‐NavasM, Fernandez‐UrienI, et al.Capsule endoscopy versus colonoscopy for the detection of polyps and cancer. N Engl J Med2009;361:264. CrossRef

153. EliakimR, YassinK, NivY, et al.Prospective multicenter performance evaluation of the second‐generation colon capsule compared with colonoscopy. Endoscopy2009;41:1026. CrossRef

154. SpadaC, De VincentisF, CesaroP, et al.Accuracy and safety of second‐generation PillCam COLON capsule for colorectal polyp detection. Therap Adv Gastroenterol2012;5:173. CrossRef

155. CreedenJ, JunkerF, Vogel‐ZiebolzS, et al.Serum tests for colorectal cancer screening. Mol Diagn Ther2011;15:129. CrossRef

156. TaoS, HundtS, HaugU, et al.Sensitivity estimates of blood‐based tests for colorectal cancer detection: impact of overrepresentation of advanced stage disease. Am J Gastroenterol2011;106:242. CrossRef

157. GrutzmannR, MolnarB, PilarskyC, et al.Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay. PLoS ONE2008;3:e3759. CrossRef

158. Lofton‐DayC, ModelF, DevosT, et al.DNA methylation biomarkers for blood‐based colorectal cancer screening. Clin Chem2008;54:414. CrossRef

159. de VosT, TetznerR, ModelF, et al.Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin Chem2009;55:1337. CrossRef

160. ChurchTR, WandellM, Lofton‐DayC, et al.Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectac cancer. Gut2014;63:317.

161. LadabaumU, AllenJ, WandellM, et al.Colorectal cancer screening with blood‐based biomarkers: cost‐effectiveness of methylated septin 9 DNA vs. current strategies. Cancer Epidemiol Biomarkers Prev2013;22:1567. CrossRef

162. KlabundeCN, SchenckAP, DavisWW. Barriers to colorectal cancer screening among Medicare consumers. Am J Prev Med2006;30:313. CrossRef

163. LadabaumU. When even people at high risk do not take up colorectal cancer screening. Gut2007;56:1648. CrossRef

164. BerkowitzZ, HawkinsNA, PeipinsLA, et al.Beliefs, risk perceptions, and gaps in knowledge as barriers to colorectal cancer screening in older adults. J Am Geriatr Soc2008;56:307. CrossRef

165. BrouwersMC, De VitoC, BahirathanL, et al.What implementation interventions increase cancer screening rates? A systematic review. Implement Sci2011;6:111. CrossRef

166. FerroniE, CamilloniL, JimenezB, et al.How to increase uptake in oncologic screening: a systematic review of studies comparing population‐based screening programs and spontaneous access. Prev Med2012;55:587. CrossRef

167. EdwardsAG, NaikG, AhmedH, et al.Personalised risk communication for informed decision making about taking screening tests. Cochrane Database Syst Rev2013;(2):CD001865.

168. SchwartzB. The Paradox of Choice: Why More is Less. New York: Harper Perennial; 2004.

169. InadomiJM, VijanS, JanzNK, et al.Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med2012;172:575. CrossRef

170. SenoreC, EderleA, BenazzatoL, et al.Offering people a choice for colorectal cancer screening. Gut2013;62:735. CrossRef

171. StockC, IhleP, SchubertI, et al.Colonoscopy and fecal occult blood test use in Germany: results from a large insurance‐based cohort. Endoscopy2011;43:771. CrossRef

172. StoopEM, de HaanMC, de WijkersloothTR, et al.Participation and yield of colonoscopy versus non‐cathartic CT colonography in population‐based screening for colorectal cancer: a randomised controlled trial. Lancet Oncol2012;13:55. CrossRef

173. MyerPA, MannalitharaA, SinghG, et al.Proximal and distal colorectal cancer resection rates in the United States since widespread screening by colonoscopy. Gastroenterology2012;143:1227. CrossRef

174. SiegelRL, WardEM, JemalA. Trends in colorectal cancer incidence rates in the U.S. by tumor location and stage, 1992–2008. Cancer Epidemiol Biomarkers Prev2012;21:411. CrossRef

175. QaseemA, DenbergTD, HopkinsRHJr, et al.Screening for colorectal cancer: a guidance statement from the American College of Physicians. Ann Intern Med2012;156:378. CrossRef

176. Network NCC. Colorectal Cancer Screening, Version 2. NCCN Clinical Practice Guidelines in Oncology, 2013. Available at: http://www.nccn.org/professionals/physician_gls/pdf/colorectal_screening.pdf. Accessed July 25, 2013.

177. Canadian Task Force on Preventive Health Care. Colorectal cancer screening. Recommendation statement from the Canadian Task Force on Preventive Health Care. Can Med Assoc J2001;165:206.

178. CastellsA, Marzo‐CastillejoM, MascortJJ, et al.[Clinical practice guideline. Prevention of colorectal cancer. 2009 update. Asociacion Espanola de Gastroenterologia]. Gastroenterol Hepatol2009;32:717 e1.

179. LeeBI, HongSP, KimSE, et al.[Korean guidelines for colorectal cancer screening and polyp detection]. Korean J Gastroenterol2012;59:65. CrossRef

180. LiebermanDA, RexDK, WinawerSJ, et al.Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi‐Society Task Force on Colorectal Cancer. Gastroenterology2012;143:844. CrossRef

181. AtkinWS, SaundersBP. Surveillance guidelines after removal of colorectal adenomatous polyps. Gut2002;51(Suppl 5):V6. CrossRef

182. CairnsSR, ScholefieldJH, SteeleRJ, et al.Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut2010;59:666. CrossRef

183. Lansdorp‐VogelaarI, KnudsenAB, BrennerH. Cost‐effectiveness of colorectal cancer screening. Epidemiol Rev2011;33:88. CrossRef

184. PignoneM, SahaS, HoergerT, et al.Cost‐effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med2002;137:96. CrossRef

185. Lansdorp‐VogelaarI, van BallegooijenM, ZauberAG, et al.Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening. J Natl Cancer Inst2009;101:1412. CrossRef

186. SharafRN, LadabaumU. Comparative effectiveness and cost‐effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies. Am J Gastroenterol2013;108:120. CrossRef

187. ZauberAG, Lansdorp‐VogelaarI, KnudsenAB, et al.Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med2008;149:659. CrossRef

188. LadabaumU, SongK. Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand. Gastroenterology2005;129:1151. CrossRef

189. EdwardsBK, WardE, KohlerBA, et al.Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer2010;116:544. CrossRef

190. SongK, FendrickAM, LadabaumU. Fecal DNA testing compared to conventional colorectal cancer ccreening methods: a decision analysis. Gastroenterology2004;126:1270. CrossRef

191. ZauberAG, Lansdorp‐VogelaarI, WilschutJ, et al.Technology Assessment: Cost‐Effectiveness of DNA Stool Testing to Screen for Colorectal Cancer. Report to AHRQ and CMS from the Cancer Intervention and Surveillance Modeling Network (CISNET) for MISCAN and SimCRC Models, 2007.

192. LadabaumU, SongK, FendrickAM. Colorectal neoplasia screening with virtual colonoscopy: when, at what cost, and with what national impact? Clin Gastroenterol Hepatol2004;2:554. CrossRef

193. Lansdorp‐VogelaarI, van BallegooijenM, ZauberAG, et al.At what costs will screening with CT colonography be competitive? A cost‐effectiveness approach. Int J Cancer2009;124:1161. CrossRef

194. SubramanianS, BobashevG, MorrisRJ. Modeling the cost‐effectiveness of colorectal cancer screening: policy guidance based on patient preferences and compliance. Cancer Epidemiol Biomarkers Prev2009;18:1971. CrossRef

195. Lansdorp‐VogelaarI, van BallegooijenM, ZauberAG, et al.Individualizing colonoscopy screening by sex and race. Gastrointest Endosc2009;70:96, e1–24. CrossRef

196. SturmerT, GlynnRJ, LeeIM, et al.Lifetime cigarette smoking and colorectal cancer incidence in the Physicians' Health Study I. J Natl Cancer Inst2000;92:1178. CrossRef

197. ChaoA, ThunMJ, JacobsEJ, et al.Cigarette smoking and colorectal cancer mortality in the cancer prevention study II. J Natl Cancer Inst2000;92:1888. CrossRef

198. MillerPE, LeskoSM, MuscatJE, et al.Dietary patterns and colorectal adenoma and cancer risk: a review of the epidemiological evidence. Nutr Cancer2010;62:413. CrossRef

199. FrezzaEE, WachtelMS, Chiriva‐InternatiM. Influence of obesity on the risk of developing colon cancer. Gut2006;55:285. CrossRef

200. SungJJ, LauJY, GohKL, et al.Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol2005;6:871. CrossRef

201. GiovannucciE. Modifiable risk factors for colon cancer. Gastroenterol Clin North Am2002;31:925. CrossRef

202. TomeoCA, ColditzGA, WillettWC, et al.Harvard Report on Cancer Prevention. Volume 3: prevention of colon cancer in the United States. Cancer Causes Control1999;10:167. CrossRef

203. ImperialeTF, WagnerDR, LinCY, et al.Using risk for advanced proximal colonic neoplasia to tailor endoscopic screening for colorectal cancer. Ann Intern Med2003;139:959. CrossRef

204. ChurchJM. A scoring system for the strength of a family history of colorectal cancer. Dis Colon Rectum2005;48:889. CrossRef

205. LinOS, KozarekRA, SchembreDB, et al.Screening colonoscopy in very elderly patients: prevalence of neoplasia and estimated impact on life expectancy. JAMA2006;295:2357. CrossRef

206. DriverJA, GazianoJM, GelberRP, et al.Development of a risk score for colorectal cancer in men. Am J Med2007;120:257. CrossRef

207. KastrinosF, AllenJI, StockwellDH, et al.Development and validation of a colon cancer risk assessment tool for patients undergoing colonoscopy. Am J Gastroenterol2009;104:1508. CrossRef

208. FreedmanAN, SlatteryML, Ballard‐BarbashR, et al.Colorectal cancer risk prediction tool for white men and women without known susceptibility. J Clin Oncol2009;27:686. CrossRef

209. ParkY, FreedmanAN, GailMH, et al.Validation of a colorectal cancer risk prediction model among white patients age 50 years and older. J Clin Oncol2009;27:694. CrossRef

210. WeiEK, ColditzGA, GiovannucciEL, et al.Cumulative risk of colon cancer up to age 70 years by risk factor status using data from the Nurses' Health Study. Am J Epidemiol2009;170:863. CrossRef

211. MaE, SasazukiS, IwasakiM, et al.10‐Year risk of colorectal cancer: development and validation of a prediction model in middle‐aged Japanese men. Cancer Epidemiol2010;34:534. CrossRef

212. YeohKG, HoKY, ChiuHM, et al.The Asia‐Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut2011;60:1236. CrossRef

213. CaiQC, YuED, XiaoY, et al.Derivation and validation of a prediction rule for estimating advanced colorectal neoplasm risk in average‐risk Chinese. Am J Epidemiol2012;175:584. CrossRef

214. RegulaJ, RupinskiM, KraszewskaE, et al.Colonoscopy in colorectal‐cancer screening for detection of advanced neoplasia. N Engl J Med2006;355:1863. CrossRef

215. FerlitschM, ReinhartK, PramhasS, et al.Sex‐specific prevalence of adenomas, advanced adenomas, and colorectal cancer in individuals undergoing screening colonoscopy. JAMA2011;306:1352. CrossRef

216. NguyenSP, BentS, ChenYH, et al.Gender as a risk factor for advanced neoplasia and colorectal cancer: a systematic review and meta‐analysis. Clin Gastroenterol Hepatol2009;7:676. CrossRef

217. RobinsonJC, MacPhersonK. Payers test reference pricing and centers of excellence to steer patients to low‐price and high‐quality providers. Health Aff (Millwood)2012;31:2028. CrossRef

218. CooperGS, KouTD, RexDK. Complications following colonoscopy with anesthesia assistance: a population‐based analysis. JAMA Intern Med2013;173:551. CrossRef

219. DominitzJA, BaldwinLM, GreenP, et al.Regional variation in anesthesia assistance during outpatient colonoscopy is not associated with differences in polyp detection or complication rates. Gastroenterology2013;144:298. CrossRef

220. LiuH, WaxmanDA, MainR, et al.Utilization of anesthesia services during outpatient endoscopies and colonoscopies and associated spending in 2003–2009. JAMA2012;307:1178. CrossRef

221. KetoverSR. Bundled payment for colonoscopy. Clin Gastroenterol Hepatol2013;11:454. CrossRef

222. BrillJV, JainR. Bundled Payments in Gastroenterology: Time for a Colonoscopy Bundle?2013; Available at: http://www.gastro.org/journals-publications/gi-quarterly-practice/aga_quarterly_practice_april_5_2013. Accessed May 2014.

223. RexDK, KahiC, O'BrienM, et al.The American Society for Gastrointestinal Endoscopy PIVI (Preservation and Incorporation of Valuable Endoscopic Innovations) on real‐time endoscopic assessment of the histology of diminutive colorectal polyps. Gastrointest Endosc2011;73:419. CrossRef

224. McGillSK, EvangelouE, IoannidisJP, et al.Narrow band imaging to differentiate neoplastic and non‐neoplastic colorectal polyps in real time: a meta‐analysis of diagnostic operating characteristics. Gut2013;62:1704. CrossRef

225. LadabaumU, FiorittoA, MitaniA, et al.Real‐time optical biopsy of colon polyps with narrow band imaging in community practice does not yet meet key thresholds for clinical decisions. Gastroenterology2013;144:81. CrossRef

226. SonodaH, KohnoeS, YamazatoT, et al.Colorectal cancer screening with odour material by canine scent detection. Gut2011;60:814. CrossRef

227. WeissfeldJL, SchoenRE, PinskyPF, et al.Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial. J Natl Cancer Inst2005;97:989. CrossRef